Ness et al. [10] found that a high expression of CD8+ in the epithelial compartment and in the total tumor was an independent predictor of shorter BCR-free survival in tissue microarrays (TMAs) from 535 RP specimens (multivariate HR: 1.45, CI 95%: 1.03–2.03, p = 0.032 and multivariate HR: 1.57, CI 95%: 1.13–2.17, p = 0.007, respectively). This evidence concerns the gene BCR and neoplasm.